Adrenomed presents new findings on its precision medicine treatment for septic shock with enibarcimab during Weimar Sepsis Update
The patient population that benefits most from treatment with enibarcimab in septic shock can be clearly defined by two biomarkers, according to data presented today
In the AdrenOSS-2 study, the relevant subgroup had a significant reduction in…